Clinical Trial Update: A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update describing a study of three malaria vaccine candidates (R78C, RH5.1, and the multi-stage R21/Matrix-M) from the University of Oxfo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria

Drugs mentioned

• R21/Matrix-M
• R78C (R78C malaria antigen)
• RH5.1 (RH5.1 malaria antigen)

Snippet

Sponsor: University of Oxford | Conditions: Malaria,Falciparum | Phase 1 | Status: RECRUITING